Overcome Biochemical Aspirin Resistance Through Cilostazol Combination "ARCC"

Completed

Phase 4 Results

Eligibility Criteria

Inclusion Criteria

- Symptomatic cerebral infarction documented on MRI or CT
- More than 35 years of age
- Patients taking aspirin 100mg a day for 2 weeks or more before randomization

Exclusion Criteria

- Patients taking any antiplatelets other than aspirin within 2 weeks before randomization
- Patients taking any anticoagulants within 2 weeks before randomization
- Patients taking thrombolytic therapy within 2 weeks before randomization
- Patients taking any NSAIDs within 2 weeks before randomization
- Patients who need to take NSAIDs regularly (e.g. rheumatic arthritis).
- Bleeding diathesis
- Chronic liver disease (ALT > 100 or AST > 100) or chronic renal disease (creatinine > 3.0mg/dl)
- Anemia (hemoglobin < 10mg/dl) or thrombocytopenia (platelet count less than 100,000/mm3)
- Pregnant or lactating patients
- Patients scheduled for angioplasty or revascularization procedures within 4 weeks
- Patients scheduled for any surgery or invasive procedures within 4 weeks
- Patients having acute coronary syndrome